Conformis Actera™ Hip System Receives 510(k) Clearance from the U.S. Food and Drug Administration
13 sept. 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced...
Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference
29 août 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis Reports Second Quarter 2022 Financial Results
08 août 2022 16h45 HE
|
Conformis, Inc.
BILLERICA, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
01 août 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc., (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced it...
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
28 juil. 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
05 juil. 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it...
Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity
24 mai 2022 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced...
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference
10 mai 2022 08h00 HE
|
Conformis, Inc.
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that...
Conformis Reports First Quarter 2022 Financial Results
04 mai 2022 07h00 HE
|
Conformis, Inc.
BILLERICA, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022
11 avr. 2022 16h30 HE
|
Conformis, Inc.
BILLERICA, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022, before the...